Preventive screening along with a healthy lifestyle can easily stop at least 80% of premature deaths from heart diseases and strokes and 40% of cancer. To enable screening in India on a large scale, Suthirth Vaidya and Abhijith Chunduru, IIT Madras graduates with research expertise in building advanced deep learning technology.

Established in 2016, Predible Health uses artificial intelligence (AI) in radiology with a focus on lung and head-related conditions. It designs and builds products for cancer radiologists.  They claim that their accuracy level is always 95%+ and can generate reports up to 2x speed. Their turnaround time is under 10 minutes

Their flagship programme, LungIQ, was built to bridge the gap of diagnosis of over 1 billion respiratory patients. It aims to detect any life-threatening condition and minimise the chances of misdiagnosis. LungIQ uses artificial intelligence to generate visual and quantitative reports from chest CT scans. Helping produce quick and efficient reports of numerous chest conditions. 

In April 2020, the venture was nominated by the Bengaluru-based incubator Centre for Cellular and Molecular Platforms (C-CAMP) as a deployment-ready COVID-19 innovation.

During the tough times of COVID-19, the healthcare workers had to work extra and that too at the risk of their own health. With screening technology, one could reduce their workload significantly. Predible Health’s LungIQ could detect COVID-19 patients from thoracic CTs by analysing the damages caused in the lungs. Where the annual subscription of LungIQ was around Rs 6 lakh. 

The software update for COVID-19 diagnosis was given for free. The venture even partnered with  Max Healthcare, Tata Memorial Hospital and Mahajan Imaging. Some of its other partners include 5C Network, MAX Healthcare and Narayana Health. 

In 2018, they raised an undisclosed Seed Round led by Unitus Ventures. Later in 2020, they raised another Seed fund round of undisclosed amounts from International Finance Corporation and Stellaris Venture Partners. Will such screening ventures help millions of Indians get faster access to early diagnosis and subsequent early treatment?